Newsroom

Our latest developments

Orca Bio’s announcements and press releases

Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies

View

Orca Bio Presents Positive Phase 1 and 1b Data on Orca-T and Orca-Q at the 2025 Tandem Meetings of ASTCT® and CIBMTR®

View

Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies

View

Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

View

Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting

View

Orca Bio Presents Clinical Results on Use of Orca-Q without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting

View

Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting

View

Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T

View

Orca Bio's fact sheets

Orca Bio Corporate Overview

View

For media inquiries,

contact us at:

media@orcabio.com
NEXT: Discover who we are